Budget impact analysis of ticagrelor for preventive treatment of patients with acute coronary syndromes
Budget impact analysis of ticagrelor for preventive treatment of patients with acute coronary syndromesBackgroundTicagrelor 90 mg BID is indicated for the prevention of thrombotic cardiovascular events in patients with acute coronary syndromes (ACS). Outcomes from the PLATO trial demonstrated that t...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2017-03-01
|
| Series: | Global & Regional Health Technology Assessment |
| Online Access: | http://www.grhta.com/Attach/1FA09374-41EA-414D-B6BA-6FA1A162C3EB/D9255A18-A611-4359-91C6-21B13006C57B |